Skip to content
10-Q

Quarterly Report

XENETIC BIOSCIENCES, INC. XBIO

0001683168-25-003496

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 1.54M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $667.93K
Current Liabilities Q1 2025 · Dec 31, 2024 $894.26K
Total Liabilities Q1 2025 · Mar 31, 2025 $667.93K
Total Liabilities Q1 2025 · Dec 31, 2024 $894.26K
Current Assets Q1 2025 · Mar 31, 2025 $5.48M
Current Assets Q1 2025 · Dec 31, 2024 $6.59M
Total Assets Q1 2025 · Mar 31, 2025 $5.79M
Total Assets Q1 2025 · Dec 31, 2024 $6.9M
Shares Diluted Q1 2025 · Mar 31, 2024 1.54M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$1.16M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $7.82M
Cash And Equivalents Q1 2025 · Dec 31, 2023 $8.98M
Stockholders Equity Q1 2025 · Mar 31, 2024 $8.68M
Stockholders Equity Q1 2025 · Dec 31, 2023 $9.8M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.78
Eps Basic Q1 2025 · Mar 31, 2024 −$0.78
Sga Expense Q1 2025 · Mar 31, 2024 $834.91K
Rd Expense Q1 2025 · Mar 31, 2024 $944.32K
Net Income Q1 2025 · Mar 31, 2024 −$1.2M
Operating Income Q1 2025 · Mar 31, 2024 −$1.27M
Revenue Q1 2025 · Mar 31, 2024 $510.82K